一个积极的SPTBN2-FLI1反轴通过PI3K/AKT激活促进膀癌症
Xiaoyan Guo1, Chenxi Zhu2, Zhuo Yin3
1Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China.
Cellular signalling
|March 6, 2026
概括
过度表达的SPTBN2通过激活PI3K/AKT通路驱动膀癌 (BLCA) 的进展. 针对SPTBN2或该途径为BLCA患者提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 膀癌 (BLCA) 呈现出高复发率和晚期的不良结果.
- SPTBN2在BLCA病变发生中的作用及其作为生物标志物的潜力尚未得到充分研究.
研究的目的:
- 研究SPTBN2在膀癌 (BLCA) 进展中的作用.
- 评估SPTBN2作为BLCA的预后生物标志物和治疗标.
主要方法:
- 在BLCA患者样本中分析SPTBN2表达.
- 在BLCA细胞系中进行功能性测试 (例如,敲击) 以评估恶性表型.
- 调查SPTBN2,FLI1和PI3K/AKT路径之间的监管循环.
- 使用PI3K抑制剂的体外和体内研究.
主要成果:
- 在BLCA中,SPTBN2显著过度表达,并且与不良的临床结果相关.
- 在BLCA细胞中,SPTBN2 Knockdown抑制了繁殖,迁移和殖民地形成.
- 确定了SPTBN2和FLI1之间的相互调节循环,激活PI3K/AKT通路并促进上皮层-介质酶过渡.
- 抑制PI3K有效地逆转了SPTBN2介导的瘤效应.
结论:
- 在膀癌中,SPTBN2作为一种新的瘤蛋白和预后生物标志物.
- SPTBN2-FLI1-PI3K/AKT信号轴是BLCA干预的有希望的治疗目标.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
6.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.0K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
The JAK-STAT Signaling Pathway
13.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.5K
Interactions Between Signaling Pathways
7.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
Intracellular Signaling Affects Focal Adhesions
3.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.7K
Cancer Cell Migration through Invadopodia
3.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K


